If you’ve been taking Ozempic or Wegovy (both of which contain the active ingredient semaglutide), you might wonder, How long ...

Is compounded semaglutide effective for weight loss? Here’s the short version: Compounded semaglutide isn’t approved by the FDA (U.S. Food and Drug Administration), so it hasn’t been proven ...

New study reveals weight-loss drugs help during treatment but weight returns rapidly after stopping. Here's what they found.

Low doses of the injectable weight-loss medication semaglutide may improve symptoms of a hard-to-treat type of heart failure.

Tirzepatide is the active ingredient in Zepbound, approved by the Food and Drug Administration (FDA) specifically for weight loss. Semaglutide was initially approved under the brand name Ozempic ...

GoodRx reports on identifying real Wegovy pens, which come in five colors and lack dose selectors. Counterfeits pose health ...

In February 2021, the FDA approved semaglutide for chronic weight management in adults who are obese or overweight and have at least one weight-related health condition, such as high blood ...

The FDA approved once-weekly semaglutide injection for chronic weight management in adults with obesity or with overweight and at least one weight-related condition, according to an agency press ...

Myth 6: Semaglutide is a permanent solution to weight loss. Many believe that once they start semaglutide, they’ll be set for life. Unfortunately, that’s not the case.

That’s simply not true in the case of the Wegovy form of semaglutide. Remember, the FDA approved Wegovy in 2021 specifically for weight loss, so it’s a weight-loss medication, not a type 2 ...

Tirzepatide and semaglutide confer greater weight loss than other FDA-approved obesity medications with no significantly higher risk for adverse events, according to findings from a network meta ...

According to a 2024 analysis published in JAMA Network Open, the annual cost of semaglutide is currently $13,618 and, while the drug is effective for weight loss, it is not an economically viable ...